98%
921
2 minutes
20
Notoginsenoside Rb1 (Rb1), a bioactive saponin from exerts cardio-cerebrovascular protective, anti-inflammatory, antioxidant, and glucose homeostasis-regulating effects. However, its oral bioavailability is limited by gastric degradation and poor intestinal permeability. This study presents a food-grade bigel system for encapsulating Rb1 to enhance its stability and controlled-release performance. Oleogels were structured using monoglycerides (8%, /) in soybean oil. Rb1-loaded binary hydrogels (gellan gum/xanthan gum, 12:1 /) were emulsified in 10% Tween-80 (/). Bigels were formulated at varying hydrogel-to-oleogel ratios, and a ratio of 4:6 was identified as optimal. Stress-sweep rheological analysis revealed a dense gel structure with a peak storage modulus (G') of 290.64 Pa-the highest among all tested ratios-indicating superior structural integrity. Confocal microscopy confirmed homogeneous encapsulation of Rb1 within the continuous hydrogel phase, effectively preventing payload leakage. Differential scanning calorimetry (DSC) analysis detected a distinct endothermic transition at 55 °C (ΔH = 6.25 J/g), signifying energy absorption that enables thermal buffering during food processing. The system achieved an encapsulation efficiency of 99.91% and retains both water and oil retention. Effective acid protection and colon-targeted delivery were observed in the digestion test. Effective acid protection and colon-targeted delivery were observed in the digestion test. Less than 5% of Rb1 was released in the gastric phase, and over 90% sustained intestinal release occurred at 4 h. The optimized bigel effectively protected Rb1 from gastric degradation and enabled sustained intestinal release. Its food-grade composition, thermal stability, and tunable rheology offer significant potential for use in functional foods and nutraceuticals.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12385552 | PMC |
http://dx.doi.org/10.3390/gels11080624 | DOI Listing |
Mater Today Bio
October 2025
Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Inflammatory diseases (IDs), characterized by chronic inflammation, are linked to conditions such as bacterial and viral infections, arthritis, and neurodegenerative disorders. Current treatments offer only temporary relief, highlighting the need for more effective therapies. Ginsenoside Rb1 (Rb1), with potent anti-inflammatory and antioxidant properties, can self-assemble into nanoparticles.
View Article and Find Full Text PDFColloids Surf B Biointerfaces
December 2025
Jilin Ginseng Academy, Innovation and Entrepreneurship College, Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, PR China. Electronic address:
This study synthesized bioactive carbon nanodots (Rb1-CDs) from ginsenoside Rb1 via hydrothermal processing. The Rb1-CDs demonstrated a uniform size distribution (5.3 ± 1.
View Article and Find Full Text PDFGels
August 2025
College of Notoginseng Medicine and Pharmacy, Wenshan University, Wenshan 663099, China.
Notoginsenoside Rb1 (Rb1), a bioactive saponin from exerts cardio-cerebrovascular protective, anti-inflammatory, antioxidant, and glucose homeostasis-regulating effects. However, its oral bioavailability is limited by gastric degradation and poor intestinal permeability. This study presents a food-grade bigel system for encapsulating Rb1 to enhance its stability and controlled-release performance.
View Article and Find Full Text PDFChin Med
August 2025
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Background: The gut microbiota plays a critical role in the biotransformation of saponins. However, current research predominantly focuses on metabolism by single microbial species, with limited investigation into inter-species differences or inter-individual variability in saponin biotransformation, especially by the culture of mixed gut microbiota. This study aims to elucidate the species-specific differences and inter-individual variability in gut microbiota-mediated saponin biotransformation through multidimensional analysis.
View Article and Find Full Text PDFJ Ginseng Res
September 2025
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Background: Ginsenoside Rb1 is a prominent bioactive component in traditional Chinese medicine.
Purpose: This study investigated the molecular mechanisms underlying the protective effects of Ginsenoside Rb1 on endothelium during ischemia-reperfusion (I/R) injury.
Materials And Methods: To enrich for marker genes and investigate the differential expression of DUSP1 and NDUFS4 in coronary artery disease, single-cell transcriptome sequencing was utilized.